Do you screen for MTHFR polymorphisms in your patients with treatment-resistant depression?
Answer from: at Academic Institution
In the trial by Papakostas et al, we have shown that adjunctive L-methylfolate at 15 mg/day had significantly greater efficacy compared with continued SSRI therapy plus placebo on both primary outcome measures (response rate and degree of change in depression symptom score) and two secondary outcome...
Comments
at Icahn School of Medicine at Mount Sinai/Mount Sinai Hospital I sometimes test but often use L-methylfolate empi...
I sometimes test but often use L-methylfolate empi...